Filing Flows › Clover Health Investments (CLOV) › Q2 2025
Clover Health Investments (CLOV) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 8, 2025
Clover Health Investments (CLOV) reported revenue of $478M for the second quarter 2025 (Q2 2025), +34% from a year earlier and +3% from the quarter before. Operating margin was -2.2%, net loss $10.6M (2.2% of revenue).
Clover Health Investments, Q2 2025: revenue $478M (+34% year over year), operating margin -2.2%, net loss $10.6M, operating cash flow $5.4M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $478M | +3% | +34% |
| Operating profit | −$10.6M | — | — |
| Net earnings | −$10.6M | — | — |
| Operating cash flow | $5.4M | — | -88% |
| Free cash flow | $4.8M | — | -89% |
What changed
Revenue was $477.6M in Q2 2025, up 34% year over year and up 3% from the previous quarter.
Operating costs exceeded revenue by $10.6M, an operating margin of -2.2%. The fastest-growing cost line was Other operating costs (+681%). The quarter ended with a net loss of $10.6M, wider than the previous quarter's $1.3M loss.
Operating cash flow was $5.4M (down 88% year over year). Non-cash charges added back $26.2M of share-based compensation. Working capital and other items used $10.2M. Capital expenditures of $569K left free cash flow of $4.8M.
Questions
What was Clover Health Investments' revenue in the second quarter 2025?
Clover Health Investments (CLOV) reported revenue of $478M for the second quarter 2025 (Q2 2025), +34% from a year earlier and +3% from the quarter before.
Was Clover Health Investments profitable in the second quarter 2025?
Operating loss was $10.6M (-2.2% of revenue) and net loss $10.6M.